article thumbnail

STAT+: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label

STAT

regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment. Novo said it has also filed for a label expansion in Europe and a decision is expected this year.

Labelling 143
article thumbnail

Rybelsus vs. Ozempic: Differences, similarities & side effects

The Checkup by Singlecare

Food & Drug Administration (FDA) for weight management, many people find they lose weight with these medications, especially with lifestyle changes like a healthy diet and regular exercise. This indication is not found on the label for Rybelsus. They’re generally not covered for off-label purposes like weight management.

Dosage 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What to do during Mounjaro shortage

The Checkup by Singlecare

The Food and Drug Administration (FDA) first reported the shortage in December 2022, but availability issues have continued long after that. In fact, as recently as April 2, 2024, the FDA announced that shortages of certain Mounjaro dosages were expected to continue at least through the end of April.

article thumbnail

Wegovy vs. Mounjaro: Differences, similarities & side effects

The Checkup by Singlecare

Food & Drug Administration (FDA) for chronic weight management in adults who either have obesity or are overweight with at least one weight-related condition , such as high blood pressure, Type 2 diabetes, or high cholesterol. Mounjaro is FDA approved to manage blood sugar levels in adults with Type 2 diabetes.

Dosage 52
article thumbnail

How to get Ozempic prescribed for weight loss

The Checkup by Singlecare

Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent. Weight loss is an off-label , non-FDA-approved use for Ozempic. The FDA has urged consumers to use caution when taking medication from these compound pharmacies.

Insurance 104
article thumbnail

How to save on Mounjaro

The Checkup by Singlecare

Mounjaro (tirzepatide) is a brand-name prescription medication that has been approved by the Food and Drug Administration (FDA) to improve blood sugar control in adults with Type 2 diabetes (along with diet and exercise). As a result, the medication is now on a fast track to get FDA approval for the treatment of obesity.”

article thumbnail

Does United Healthcare cover Wegovy for weight loss?

The Checkup by Singlecare

Wegovy is an injectable prescription medication approved by the Food and Drug Administration (FDA) for treating obesity. You can save up to $225 when using this discount card with insurance and up to $500 without insurance. Wegovy insurance coverage The Wegovy website offers tips for gaining Wegovy insurance coverage.